Pluslife MiniDock MTB Test Receives ERPD Listing

Pluslife is pleased to announce that our MiniDock MTB Test has been officially listed under the Expert Review Panel for Diagnostics (ERPD). This listing confirms the product's eligibility for procurement in Global Fund-supported programs.

The listing supports the product's inclusion in international procurement frameworks, following an independent quality assessment.

At Pluslife, we are dedicated to making high-quality molecular diagnostics more accessible, affordable, and practical for real-world use. We believe that enabling accurate diagnosis closer to the patient is essential to improving treatment timelines and health outcomes. Through continued innovation and collaboration, we aim to support public health programs and healthcare providers in delivering timely and effective diagnostic solutions, especially in settings with limited resources or infrastructure.